Many women expect hot flashes.
They expect irregular periods.
They expect night sweats.
What they don't expect is waking up one morning feeling like a completely different person.
Perhaps you've always considered yourself calm, organized, and emotionally resilient. You've successfully navigated college, career changes, raising children, financial stress, and life's inevitable ups and downs without struggling with significant anxiety.
Then, seemingly without warning, your body begins to respond differently.
Your heart races during meetings.
You lie awake for hours replaying conversations.
You begin worrying about things that never used to concern you.
You feel constantly "on edge," even when nothing is objectively wrong.
Some women experience their first panic attack during perimenopause and are convinced they're having a heart attack. Others become fearful that they're developing dementia because they can no longer think as clearly as they once did. Many wonder if they're simply "losing it."
If any of this sounds familiar, you're not alone—and more importantly, you're not imagining it.
Anxiety is one of the most common psychological symptoms experienced during the menopausal transition. While psychosocial stressors certainly contribute, decades of research have demonstrated that fluctuating reproductive hormones directly influence the brain systems responsible for emotional regulation, fear processing, sleep, cognition, and resilience to stress (The Menopause Society [TMS], 2022; Lega et al., 2023).
Understanding why anxiety develops during perimenopause is important because it helps replace fear with knowledge. When women recognize that these symptoms have a biological basis, they are often better equipped to seek appropriate evaluation and evidence-based treatment rather than blaming themselves or assuming they simply need to "push through."
Most public conversations about menopause focus almost exclusively on physical symptoms.
Television commercials discuss hot flashes.
Magazine articles discuss hormone therapy.
Friends compare stories about irregular periods.
Far less attention is given to the emotional and cognitive symptoms that frequently accompany hormonal change.
Research suggests that clinically significant anxiety symptoms increase during the menopausal transition, particularly during late perimenopause when estrogen fluctuations become increasingly unpredictable (Lega et al., 2023). Women with a previous history of anxiety disorders are at increased risk for symptom recurrence, but importantly, many women experience clinically meaningful anxiety for the first time during midlife (Gordon et al., 2021).
This distinction matters.
When anxiety develops in someone who has never previously struggled with mental health concerns, it can feel frightening and confusing. Many women spend months searching for cardiac, neurological, or endocrine explanations before considering that hormonal changes may be contributing to what they're experiencing.
The symptoms themselves vary considerably from person to person.
Some women experience generalized anxiety characterized by constant worrying and persistent tension.
Others experience panic attacks with sudden episodes of intense fear accompanied by racing heart, chest tightness, dizziness, shortness of breath, and trembling.
Still others describe a constant sense of internal restlessness they cannot explain.
Common symptoms include:
Although these symptoms are common, they should never simply be dismissed as "normal." Anxiety that interferes with work, relationships, sleep, or quality of life deserves careful evaluation and treatment.
One of the biggest misconceptions about estrogen is that it exists solely to regulate reproduction.
In reality, estrogen functions as a powerful neuroactive hormone.
Estrogen receptors are widely distributed throughout the brain, particularly within the hippocampus, amygdala, hypothalamus, anterior cingulate cortex, and prefrontal cortex—regions responsible for memory formation, emotional regulation, executive functioning, stress response, and decision-making (Brinton, 2024).
Throughout the reproductive years, estrogen helps maintain communication between neurons and supports several neurotransmitter systems involved in mood regulation.
During perimenopause, however, estrogen production becomes increasingly erratic.
Rather than declining gradually, estrogen levels fluctuate dramatically from cycle to cycle. These fluctuations appear to have a greater impact on mood than low estrogen alone, which helps explain why many women report their emotional symptoms are actually worse during perimenopause than after menopause (TMS, 2022).
From a psychiatric perspective, this period represents a time of increased vulnerability because hormonal instability influences multiple neurochemical pathways simultaneously.
Understanding those pathways helps explain why anxiety develops.
Serotonin is often referred to as the brain's "feel-good" neurotransmitter, although its functions extend far beyond mood.
Serotonin influences emotional regulation, sleep, appetite, pain perception, cognitive flexibility, and anxiety.
Estradiol enhances serotonergic neurotransmission through several mechanisms. It increases serotonin synthesis by influencing tryptophan hydroxylase activity, decreases serotonin degradation through reduced monoamine oxidase activity, and enhances postsynaptic serotonin receptor sensitivity (Shanmugan & Epperson, 2021).
When estrogen fluctuates dramatically during perimenopause, these protective effects become less consistent.
The result may be increased emotional sensitivity, excessive worry, irritability, and heightened anxiety, particularly in women who are already genetically susceptible to mood disorders.
This also helps explain why some women who have responded well to antidepressant medications for years suddenly notice worsening symptoms during the menopausal transition. Their underlying neurobiology has changed, even if their medication regimen has not.
Progesterone is often overshadowed by estrogen in discussions about menopause, but it also plays an important role in mental health.
Progesterone is metabolized into allopregnanolone, a neurosteroid that enhances activity at GABA-A receptors.
GABA is the brain's primary inhibitory neurotransmitter. It functions much like a brake pedal, reducing excessive neuronal firing and promoting calmness.
As progesterone production becomes increasingly inconsistent during perimenopause, allopregnanolone levels also fluctuate. This may reduce GABA-mediated inhibition and contribute to increased anxiety, emotional lability, sleep disturbance, and heightened stress sensitivity (Shanmugan & Epperson, 2021).
Many women describe this as feeling like they have "lost their emotional buffer."
Situations they once managed without difficulty now feel exhausting.
Minor inconveniences provoke disproportionate emotional reactions.
Stress feels harder to recover from.
These experiences are consistent with the underlying neurobiology occurring during the menopausal transition.
While serotonin and GABA receive much of the attention in discussions about anxiety, dopamine plays an equally important role—particularly for women who notice changes in motivation, concentration, and emotional regulation during perimenopause.
Dopamine is responsible for much more than pleasure. It helps regulate attention, working memory, motivation, decision-making, reward processing, and executive functioning. Estrogen enhances dopaminergic activity within the prefrontal cortex, the area of the brain responsible for planning, organizing, problem-solving, impulse control, and emotional regulation (Shanmugan & Epperson, 2021).
As estrogen becomes increasingly unpredictable during perimenopause, dopamine signaling may become less efficient. Many women describe this as feeling mentally "slower" or "less capable" despite having no underlying cognitive disease.
You may notice that:
These cognitive changes often increase anxiety.
Many women begin questioning their competence at work or worrying that they are developing dementia. Others become increasingly self-critical, believing they are somehow failing despite years of success.
In reality, these symptoms often reflect temporary neurochemical changes rather than permanent cognitive decline (Maki & Jaff, 2022).
One of the most frightening experiences during perimenopause is having a panic attack without any previous history of anxiety.
Panic attacks are episodes of sudden, intense fear that typically peak within minutes and may include:
Many women seek emergency medical care because the symptoms closely resemble a heart attack.
Although panic attacks are not caused solely by hormonal changes, fluctuating estrogen, declining progesterone, disrupted sleep, increased stress sensitivity, and heightened autonomic nervous system activation create an environment in which panic symptoms are more likely to occur (Lega et al., 2023).
Importantly, panic attacks should never be assumed to be "just menopause." Chest pain, fainting, severe shortness of breath, neurological symptoms, or new cardiovascular symptoms always warrant prompt medical evaluation.
Once serious medical conditions have been excluded, understanding the role of hormonal changes can help reduce the fear that often perpetuates future panic attacks.
One of the most common statements I hear from women during perimenopause is:
"I know this shouldn't bother me this much."
That observation is often accurate.
The body responds to stress through the hypothalamic-pituitary-adrenal (HPA) axis, which regulates cortisol production. Estrogen interacts with this system and appears to influence how the brain perceives and recovers from stressful events (Albert et al., 2023).
During perimenopause, fluctuating hormone levels may contribute to increased physiological stress reactivity. Challenges that once felt manageable—an unexpected bill, a disagreement with a spouse, a busy day at work—may suddenly trigger a much stronger emotional response.
This does not mean women become emotionally weaker during midlife.
Instead, it reflects temporary changes in the biological systems responsible for stress regulation.
When these hormonal changes occur alongside chronic sleep deprivation, caregiving responsibilities, career pressures, and other midlife stressors, anxiety can escalate quickly.
Sleep deserves special attention because it sits at the center of nearly every mental health symptom experienced during perimenopause.
Night sweats, insomnia, frequent awakenings, restless sleep, and early-morning waking become increasingly common during the menopausal transition. Unfortunately, sleep loss doesn't simply make you tired—it changes how your brain functions.
Research demonstrates that inadequate sleep impairs emotional regulation, increases amygdala activation (the brain's threat detector), reduces activity within the prefrontal cortex, and increases physiological responses to stress (Maki & Jaff, 2022).
Poor sleep also contributes to:
Many women mistakenly believe anxiety is causing their insomnia.
While that is certainly possible, the relationship works both ways.
Poor sleep increases anxiety.
Anxiety worsens sleep.
Breaking this cycle is often one of the most important components of treatment.
Because anxiety can present with such a wide range of physical and psychological symptoms, it is important not to assume hormones are the only explanation.
A comprehensive psychiatric and medical evaluation should consider other potential contributors, including:
Both hyperthyroidism and hypothyroidism may produce symptoms that overlap with anxiety, including palpitations, fatigue, irritability, weight changes, tremor, and sleep disturbance.
Iron deficiency, with or without anemia, can contribute to fatigue, reduced concentration, restless legs syndrome, and worsening anxiety.
Vitamin B12 deficiency may produce cognitive symptoms, neuropathy, fatigue, and mood changes that resemble anxiety or depression.
Obstructive sleep apnea becomes more common after menopause and frequently presents with fatigue, poor concentration, irritability, morning headaches, and worsening anxiety.
Palpitations should never automatically be attributed to anxiety without appropriate evaluation, particularly in women with cardiovascular risk factors.
Many women receive an ADHD diagnosis during perimenopause because hormonal changes expose executive functioning difficulties that were previously compensated for. Distinguishing ADHD from anxiety is essential because treatment strategies differ substantially.
Depression and anxiety commonly occur together.
Some women primarily report anxiety while underlying depression goes unrecognized. Others describe irritability or emotional numbness rather than sadness.
Because these conditions frequently overlap, an accurate diagnosis requires looking beyond a single symptom.
At Synchronous Mental Health, one of the most common misconceptions we hear is:
"I've never had anxiety before, so this can't be anxiety."
In reality, first-onset anxiety during perimenopause is something we see regularly.
Equally common are women who have spent months searching for answers after normal cardiac testing, thyroid studies, or neurological evaluations. They know something has changed, but no one has connected the dots between hormonal changes, sleep disruption, stress physiology, and mental health.
Our goal is not simply to prescribe medication.
Instead, we work to understand why anxiety has developed.
For one patient, untreated sleep apnea may be the primary driver.
For another, worsening ADHD may be creating chronic overwhelm.
For someone else, significant vasomotor symptoms may be fragmenting sleep every night.
Still another patient may benefit from psychotherapy, medication, menopausal hormone therapy coordinated with her gynecologist, or a combination of approaches.
The treatment plan should fit the individual—not the diagnosis.
Perhaps the most important message I want every woman to take away from this article is this:
You do not have to accept feeling anxious simply because you are entering menopause.
Although hormonal changes are unavoidable, suffering is not.
Evidence-based treatments are available, and most women experience meaningful improvement when the underlying contributors are identified and addressed.
Recognizing symptoms early, obtaining a comprehensive evaluation, and developing an individualized treatment plan can help restore emotional well-being and improve quality of life during this important transition.
The best treatment for anxiety during perimenopause depends on the individual woman.
There is no single medication, supplement, hormone, or lifestyle intervention that works for everyone. Anxiety during the menopausal transition is often multifactorial, meaning several biological, psychological, and social factors contribute simultaneously.
An effective treatment plan begins with understanding why anxiety has developed.
For one woman, chronic sleep deprivation caused by night sweats may be the primary driver. For another, untreated ADHD may be creating constant overwhelm. Another patient may have underlying generalized anxiety disorder that has become more symptomatic because hormonal fluctuations have reduced her resilience to stress.
Rather than asking, "What medication treats menopause anxiety?" a better question is:
"What factors are contributing to my anxiety?"
The answer guides treatment.
Lifestyle interventions should not be viewed as "alternative medicine." They are supported by a growing body of evidence and often improve both physical and mental health.
Exercise is one of the most consistently recommended interventions for women during the menopausal transition.
Regular physical activity has been shown to improve anxiety, depressive symptoms, sleep quality, cardiovascular health, insulin sensitivity, and overall quality of life (Lega et al., 2023).
Current guidelines recommend aiming for:
Exercise appears to influence multiple neurotransmitters involved in mood regulation, including serotonin, dopamine, and endorphins, while also reducing inflammatory markers associated with depression and anxiety.
Although there is no specific "menopause diet," overall dietary quality influences mental health.
Research increasingly supports a Mediterranean-style eating pattern emphasizing:
Highly processed foods, excessive refined carbohydrates, and heavy alcohol consumption have been associated with poorer mental health outcomes and may worsen sleep quality in some individuals (Lega et al., 2023).
At Synchronous Mental Health, we also evaluate whether metabolic conditions such as insulin resistance, obesity, or type 2 diabetes may be contributing to mood symptoms. Mental health and metabolic health are closely connected, and addressing both often produces better outcomes than focusing on either alone.
Stress cannot always be eliminated, but it can often be managed more effectively.
Evidence-based approaches include:
These strategies are not intended to replace medical treatment when clinically indicated, but they can reduce overall stress reactivity and improve emotional resilience.
If I could improve only one aspect of health for many women experiencing anxiety during perimenopause, it would often be sleep.
Chronic sleep disruption affects nearly every brain system involved in emotional regulation.
Poor sleep increases:
Improving sleep may involve:
CBT-I is considered the first-line treatment for chronic insomnia and has demonstrated sustained benefits that often exceed those of sleep medications over the long term (NICE, 2024).
Psychotherapy remains one of the most effective treatments for anxiety during perimenopause.
CBT helps individuals identify and modify patterns of thinking and behavior that contribute to anxiety.
It has demonstrated effectiveness for:
Importantly, CBT does not eliminate hormonal fluctuations. Instead, it helps reduce the emotional suffering that often accompanies them.
ACT focuses less on eliminating uncomfortable thoughts and more on developing psychological flexibility.
Many women appreciate ACT because it helps them respond differently to anxiety rather than becoming trapped in cycles of fear and avoidance.
Mindfulness interventions have demonstrated modest but meaningful improvements in anxiety, stress, and quality of life during the menopausal transition.
For women with moderate to severe anxiety, psychiatric medications may play an important role.
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) remain first-line pharmacologic treatments for most anxiety disorders (American Psychiatric Association, 2022).
Some antidepressants may also reduce vasomotor symptoms such as hot flashes, providing additional benefit for selected patients.
Medication decisions should always consider:
No medication is appropriate for everyone, and treatment should always involve shared decision-making.
Many women ask whether hormone therapy will "fix" anxiety.
The answer is more nuanced than a simple yes or no.
According to The Menopause Society, menopausal hormone therapy (MHT) remains the most effective treatment for vasomotor symptoms such as hot flashes and night sweats (TMS, 2022).
Improving these symptoms frequently improves:
Some women also experience improvement in mood and anxiety, particularly when these symptoms occur alongside significant vasomotor symptoms.
However, MHT is not considered a primary treatment for generalized anxiety disorder or major depressive disorder.
Instead, it should be viewed as one component of a comprehensive treatment plan when clinically appropriate.
The decision to initiate hormone therapy should involve a thorough discussion of risks, benefits, contraindications, and individual treatment goals with an appropriately trained clinician.
Many women wait months—or even years—before seeking help because they assume anxiety is simply part of aging.
It isn't.
Consider scheduling an evaluation if:
Early treatment often prevents symptoms from becoming more severe.
Perimenopause represents one of the most significant periods of hormonal and neurological change in a woman's life.
Fluctuating estrogen and progesterone influence serotonin, dopamine, GABA, and stress-response systems that regulate mood, attention, emotional resilience, and sleep.
The result may be new or worsening anxiety—even in women who have never experienced an anxiety disorder before.
The encouraging news is that these symptoms are common, medically recognized, and highly treatable.
Treatment may include lifestyle modifications, psychotherapy, psychiatric medications, menopausal hormone therapy when appropriate, or—most often—a combination of these approaches tailored to the individual.
You do not have to simply "live with it."
Yes. Many women experience clinically significant anxiety for the first time during the menopausal transition. Hormonal fluctuations, sleep disruption, changing stress physiology, and life circumstances all contribute (Lega et al., 2023).
Nighttime awakenings are common during perimenopause because of vasomotor symptoms, hormonal fluctuations, and changing sleep architecture. Once awake, increased cortisol levels and heightened sympathetic nervous system activity can make it difficult to return to sleep.
Not necessarily. Hormone therapy is highly effective for treating vasomotor symptoms and may improve mood in some women, but it is not considered a primary treatment for anxiety disorders (TMS, 2022).
Yes. Panic attacks can cause chest pain, palpitations, shortness of breath, dizziness, and sweating. However, new or severe cardiac symptoms should always be evaluated promptly to rule out medical causes.
For many women, anxiety improves as hormones stabilize and contributing factors such as poor sleep, untreated ADHD, depression, or chronic stress are addressed. Seeking evaluation early often leads to better outcomes.
American Psychiatric Association. (2022). Practice Guideline for the Treatment of Patients With Anxiety Disorders.
Albert, K. M., Newhouse, P. A., & Dalton, K. M. (2023). Neuroendocrine mechanisms of mood and anxiety disorders during the menopausal transition. Current Psychiatry Reports.
Brinton, R. D. (2024). Estrogen regulation of brain health across the female lifespan. Nature Reviews Endocrinology.
Gordon, J. L., et al. (2021). Depression and anxiety during the menopause transition: Clinical considerations and treatment implications. Current Psychiatry Reports.
Lega, I. C., et al. (2023). A pragmatic approach to the management of menopause. Canadian Medical Association Journal, 195(19), E677-E685.
Maki, P. M., & Jaff, N. G. (2022). Cognitive changes during the menopause transition. Obstetrics and Gynecology Clinics of North America, 49(4), 635-648.
National Institute for Health and Care Excellence. (2024). Menopause: Identification and management (NG23). https://www.nice.org.uk/guidance/ng23
Shanmugan, S., & Epperson, C. N. (2021). Estrogen and the prefrontal cortex: Implications for women's mental health. Frontiers in Neuroscience, 15, 659516.
The Menopause Society. (2022). The 2022 hormone therapy position statement of The Menopause Society. Menopause, 29(7), 767-794.
